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Abstract  
AIM: Preeclampsia (PE) is a major cause of maternal and neonatal morbidity and mortality. There 
is a genetic component in the development of PE with estimated heritability around 0.47. Several 
studies have investigated the association between maternal ABO blood groups (OMIM: 110300) 
and risk of PE, with contradictory results have emerged. Considering that there is no study in this 
filed from Iranian population, the present case-control study was carried out at Shiraz (south-west 
Iran).  
MATERIAL AND METHODS: In this study 331 women; 121 pregnant with PE and 210 
normotensive pregnant women were included. Using blood group O (for ABO blood groups) or Rh+ 
(for Rh blood groups) as a reference, odds ratios (ORs) and its 95% confidence intervals (95% CI) 
of PE risk were estimated from logistic regression analysis.  
RESULTS: Although the A (OR = 0.67, 95% CI = 0.39-1.17, P = 0.165), B (OR = 0.86, 95% CI = 
0.48-1.53, P = 0.615) and AB (OR = 1.14, 95% CI = 0.37-3.45, P = 0.812) phenotypes showed 
lower risks compared with the O blood group, statistical analysis indicated that there was no 
significant association between ABO phenotypes and risk of PE. The frequency of Rh- phenotype 
was higher among PE patients compared with the control group. However, the association was not 
significant (OR = 1.79, 95% CI = 0.69-4.65, P = 0.229). Adjusted ORs for age of participants and 
parity did not change the above-mentioned associations.  
CONCLUSION: Our present findings indicate that there is no association between ABO and Rh 
blood groups and risk of PE in Iranian population. 
 
 
 
 
Introduction 
 
 Preeclampsia (PE) is a major cause of 
maternal and neonatal morbidity and mortality in 
humans. It is characterised by the presence of high 
blood pressure and proteinuria after the 20
th
 week of 
pregnancy. It has been reported that PE is one of the 
top four causes of maternal mortality and morbidity 
worldwide [1]. For decades many studies investigate 
the pathogenesis and risk factors of PE with hopes of 
finding ways for prevention, early detection and 
effective management. It is well established that there 
is a genetic component in the development of PE [2-
4].  
 Its heritability was estimated around 0.47 
[2]. Genome-wide scans indicate that several 
chromosomal segments are associated with risk of PE 
[5, 6]. Consanguineous marriages are associated with 
increased risk of PE [7], indicating that homozygosity 
for variant alleles involved in PE. 
 The ABO blood group was discovered in 
1900 by Karl Landsteiner. It is one of best known 
genetic traits because of its importance in transfusion 
medicine. In this blood group system, there are four 
major phenotypic groups named by A, B, AB, and O 
that result from 3 major alleles (A, B, and O) of the 
ABO gene (OMIM: 110300). The ABO gene encodes 
a glycosyltransferase that catalyses the transfer of 
carbohydrates to the H antigen (FUT1; OMIM: 
211100), forming the antigenic structures of the ABO 
phenotypes. The proteins were encoded by the A and 
B alleles of ABO catalyse the transfer of different 
carbohydrates onto the H antigen to form the A or B 
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antigens. In the O blood group, the A and B antigens 
did not produce. The gene encoding ABO blood group 
was localised on human chromosome 9q34 [8]. The 
ABO antigens are highly expressed by some human 
cells and tissues including epithelia, platelets, 
vascular endothelia and neurones [9, 10]. There is a 
large body of evidence supporting the notion that ABO 
antigens are involved in the pathogenesis of various 
systemic multifactorial traits, including cancers, 
infectious, neurological and cardiovascular disorders 
[10-12].
 
 It should be noted that although the exact 
mechanism of PE pathogenesis remains unknown, it 
seems that placenta plays the main role. Overall the 
pathogenesis consists of decreasing placental 
circulation which causes increasing maternal 
endothelial dysfunction all of which leads to clinical 
presentations of preeclampsia such as hypertension 
and protein urea [13]. It is reported that genes 
responsible for thrombophilia are associated with an 
increased risk of preeclampsia [14]. 
 
 Over many years, studies have investigated 
the association between maternal ABO blood groups 
and risk of PE, although contradictory results have 
emerged [15-21]. Based on our knowledge there is no 
study in this filed from Iranian population. Therefore 
present study was carried out.
 
 
 
Material and Methods 
 
 Study design 
 The present case-control study was 
conducted at Hafez Hospital (Shiraz, Iran) by 
reviewing medical files for pregnant women. PE was 
defined as pregnancy-induced hypertension (systolic 
blood pressure > 140 mmHg and diastolic blood 
pressure > 90 mm Hg) plus significant proteinuria 
(repeatedly ≥ 0.3 g/l or ≥ 0.5 g/24 hours or dipstick ≥+ 
representing values ≥ 0.3 g/l) after 20 weeks of 
gestational age in an earlier normotensive woman. 
The controls were pregnant women presented for 
delivery, with blood pressure values < 139/89 mmHg 
and no proteinuria recorded during the antenatal visits 
or at the time of delivery. Women with a twin 
pregnancy were excluded from PE and control 
groups. This study included 331 women; 121 pregnant 
with PE and 210 normotensive pregnant women. The 
ABO and Rh phenotypes were determined by 
standard serology methods.  
Because Iranian population is one of the most 
heterogeneous populations [22-24], we select our 
participants (patients and controls) from Persian 
(Caucasians) Muslims living in Shiraz (Fars Province, 
South-West Iran).  
 Statistical analysis 
 For the control group, the observed 
frequencies of the ABO phenotypes were assessed 
for Hardy-Weinberg equilibrium using the 
2
 statistic 
[25]. To analyse differences between cases and 
controls, we used t-test (for continuous variables), 
logistic regression (for categorical variables). Using 
blood group O (for ABO blood groups) or Rh
+
 (for Rh 
blood groups) as a reference, odds ratios (ORs) and 
its 95% confidence intervals (95% CI) of PE risk were 
estimated from logistic regression analysis. Also, 
logistic regression models were used to ORs adjusted 
for potential confounding factors. Statistical analysis 
was performed using the Statistical Package for 
Social Sciences (SPSS Inc., Chicago, IL, USA; 
version 11.5). Values of P<0.05 were considered as 
statistically significant.  
 
 
Results 
 
Table 1 shows selected characteristics factors 
in study groups. There was significant difference 
between cases and control group for age (t = 4.7, df = 
329, P < 0.001). It should be noted that there was no 
association between parity and PE (OR = 0.76, 95% 
CI: 0.48-1.20, P = 0.241).  
Table 1: Selective characteristic and blood groups among 
healthy pregnant women controls and preeclamptic patients 
Characteristic 
 
Controls Cases 
 
Results of comparison 
Number 210 121 - 
Age (years)  27.4 ± 5.6* 30.5 ± 6.1  P < 0.001 
Systolic BP (mmHg)  109.9 ± 7.8 154.7 ± 17.4  P < 0.001 
Diastolic BP (mmHg)  71.2 ± 7.1 97.6 ± 9.5  P < 0.001 
Parity      
Nulliparity  110 (52.4 %) 73 (60.3 %)  P = 0.282 
Other parities  95 (45.2 %) 48 (39.7 %)   
Missing  5 (2.4 %) 0   
ABO blood groups     
O  93 (44.3 %) 61 (50.4 %)  P = 0.536 
A  63 (30.0 %) 28 (23.1 %)   
B  46 (21.9 %) 26 (21.5 %)   
AB  8 (3.8 %) 6 (5.0 %)   
Rh Blood Groups
    
Rh
+
  201 (95.7 %) 112 (92.6 %)  P = 0.223 
Rh
-
  9 (4.3 %) 9 (7.4 %)   
* Expressed as mean ± standard deviation (SD). 
 
Table 1 also shows the prevalence of the 
ABO and Rh phenotypes in PE patients and healthy 
control pregnant women. The phenotypic frequencies 
of the ABO were in accordance with Hardy–Weinberg 
equilibrium in control group (
2 
= 1.47, df = 1, P = 
0.223). Although the A (OR = 0.67, 95% CI = 0.39-
1.17, P = 0.165), B (OR = 0.86, 95% CI = 0.48-1.53, P 
= 0.615) and AB (OR = 1.14, 95% CI = 0.37-3.45, P = 
0.812) phenotypes showed lower risks compared with 
the O blood group, statistical analysis indicated that 
there was no significant association between ABO 
phenotypes and risk of PE. To further evaluate the 
possible influence of difference of age of participants 
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and parity between the patient and control groups, as 
two confounding factors on the relationship between 
ABO blood groups and risk of PE, multiple logistic 
regression analysis was used. After adjustment for 
age of participants and parity, the same result was 
revealed (Table 2). Our present finding of no 
association between ABO blood groups and risk of PE 
is consistent with some reports [16, 17]. It should be 
noted that some researchers find the significant 
association between ABO blood groups and risk of PE 
[15, 18-21, 27].
 
Table 2: Association between ABO and Rh blood groups and 
risk of preeclampsia 
Phenotypes  
Crud OR 
 
Adjusted OR* 
OR 95% CI P OR 95% CI P 
ABO blood groups        
O  1.0 - -  1.0 - - 
A  0.67 0.39-1.17 0.165  0.71 0.40-1.28 0.263 
B  0.86 0.48-1.53 0.615  0.86 0.47-1.59 0.644 
AB  1.14 0.37-3.45 0.812  0.86 0.26-2.86 0.811 
Non-O  0.78 0.49-1.22 0.282  0.78 0.49-1.26 0.326 
Rh blood groups        
Rh
+
  1.0 - -  1.0 - - 
Rh
-
  1.79 0.69-4.65 0.229  1.64 0.61-4.42 0.322 
*Adjusted ORs for the age of participants and parity.
 
 
On the other hand, the Rh
-
 phenotype showed 
the higher risk for PE compared with the Rh
+
 
phenotype. However, the association was no 
significant (OR = 1.79, 95% CI = 0.069-4.65, P = 
0.229). Adjusted OR for the age of participants and 
parity did not change the above-mentioned 
association (Table 2). This finding is not consistent 
with previous reports [19]. 
 
 
 
Discussion 
 
It has been reported that the A [20], AB [15, 
18, 19, 27] and O [21] blood groups were the risk 
factor for PE. It is suspected that PE may result from 
changes in ischaemic vascular function [26] which can 
be influenced by ABO blood groups [27]. It should be 
noted that previous studies exploring ABO blood 
groups in women with PE revealed a great 
controversy between published studies [15-21]. While 
some studies reported the associations of ABO blood 
groups with PE [15, 18-20, 27], other studies failed to 
reach similar conclusions [16, 17]. Previously it has 
been reported that several genetic polymorphisms 
showed dissimilar associations with multifactorial 
complex traits among different ethnic groups [28-32]. 
Finally, it should mention that small sample size in 
studies and ethnicity are potential sources of 
heterogeneity between studies. 
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